/KASE, January 18, 13/ - JSC "Chimpharm" (Shymkent, hereinafter - the Company), whose securities are officially listed at Kazakhstan Stock Exchange (KASE), has by an official letter informed KASE of the following:

quote

The company is aware that there are rumors on the market that Kazakhstan's government considers the possibility of making changes to the rules governing state procurement under long-term agreements on medicines supply. In case of making of changes to the rules, and if such changes have retroaction that may affect the existing long-term agreement on medicines supply made between LLP "SK - Pharmatsyja" and the Company. However, in the Company's opinion that will not affect its capability of paying coupon interest and principal on bonds.

unquote

[2013-01-18]